![]() |
市场调查报告书
商品编码
1548114
全球胜肽合成市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测Global Peptide Synthesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
预计到2032年,全球胜肽合成市场的市场规模将从2023年的6.9069亿美元达到近22.639亿美元,2024-2032年研究期间的复合年增长率为14.1%。
胜肽具有广泛的生物功能,例如抗氧化特性、荷尔蒙功能、抗菌剂、临床诊断,并且还可作为生长因子。此外,由于其特异性高、化学空间大、易于合成、生物活性、低毒性和易于获得,它们也作为潜在的活性药物成分用于药物开发。它们也被用于治疗多种疾病,包括心血管疾病、癌症、呼吸系统疾病等。由于胜肽生产中的各种技术进步,肽分子在营养和医疗保健行业中获得了巨大的发展动力。例如,化学合成被认为是传统且广泛使用的胜肽合成技术;然而,该过程缺乏特异性,增加了环境负担的风险。因此,这导致了酶法技术用于肽合成的应用。
市场动态
肽在药品生产中的使用不断增加推动了市场的成长。肽是具有多种生物功能的高度特异性和活性药物,被广泛应用于治疗领域。糖尿病、肿瘤学和肥胖症是胜肽产生数十亿美元利润的三大治疗领域。根据美国国家癌症研究所的研究,2018年美国诊断出1,735,350例癌症病例。因此,疾病状况的上升推动了全球胜肽合成市场的成长。此外,肽合成市场研发活动的增加也有助于市场成长。为了克服全球健康挑战,研究实体的参与和对先进创新生物基产品的投资不断增加,对市场成长产生了积极影响。然而,胜肽合成过程中的污染问题加上监管标准缺乏升级,限制了市场的发展。多家公司正在开发先进的胜肽生产技术,预计在未来几年为市场创造利润丰厚的机会。例如,New England Peptide Inc.使用名为Pep Trend系统的独特软体程式来设计和生产客製化胜肽。
该报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。
此外,这些工具还对全球肽合成市场中的每个应用/产品领域进行包容性评估。
市场区隔
整个胜肽合成市场已细分为产品、应用、技术和最终用户。该报告根据地理细分对这些子集进行了分析。这项研究将使行销人员了解情况,并有助于确定产品或服务的目标族群。
本节涵盖区域细分,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的胜肽合成市场当前和未来的需求。此外,该报告重点关注所有主要地区对个别应用领域的需求。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。胜肽合成市场的主要参与者包括Genscript Biotech、Merck KGaA、Bachem Holdings、Biotage、CEM Corporation、Thermo Fisher、Creative Diagnostics、Polypeptide Group、Syngene、PuroSynth、Lonza、MP Biomedicals 和Novo Nordisk A/S。本节包括竞争格局的整体视图,其中包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Peptide Synthesis Market is presumed to reach the market size of nearly USD 2263.9 Million by 2032 from USD 690.69 Million in 2023 with a CAGR of 14.1% under the study period 2024 - 2032.
Peptides possess broad range of biological functions such as anti-oxidant properties, hormonal functions, antimicrobial agents, clinical diagnosis, and also act as growth factors. Furthermore, they are also used in drug development as potential active pharmaceutical ingredients owing to their high specificity, large chemical space, ease of synthesis, biological activity, low toxicity, and ready availability. They are also exploited in the treatment of several diseases including cardiovascular diseases, cancer, respiratory disorders, and others. Peptide molecules gained immense momentum in nutrition and healthcare industries attributed to the various technological advancements in the peptide production. For instance, chemical synthesis is considered as the traditional and widely used technology for peptide synthesis; however, the process lacked specificity and increased the risk of environmental burdens. Therefore, this caused the adoption of enzymatic technology for peptide synthesis.
Market Dynamics
Escalating usage of peptides in the production of pharmaceutical drugs propels the market growth. Peptides are highly specific and active drugs with diverse biological functions that are used in a broad range of therapeutic areas. Diabetes, oncology, and obesity are the three major therapeutic areas in which peptides generate profits in billions of dollars. According to the research study by National Cancer Institute, 1,735,350 cancer cases were diagnosed in the U.S in 2018. Additionally, owing to the growing sedentary lifestyle among populace increases the chances of obesity. Therefore, rising disease conditions boost the growth of global peptide synthesis market. Moreover, the increase in research & development activities in the peptide synthesis market also contributes to the market growth. The rising participation of research entities and investment for the advanced and innovative bio-based products in order to overcome the global health challenges positively influences the market growth. However, contamination issues during the course of peptide synthesis coupled with lack of upgradation in regulatory standards acts as a restrain for the market progression. Various companies are developing advanced technologies for peptide production, and it is anticipated to create lucrative opportunities for the market in the coming years. For example, New England Peptide Inc. uses a unique software program named Pep Trend system, to design and produce custom peptides.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of peptide synthesis.
Market Segmentation
The entire peptide synthesis market has been sub-categorized into product, application, technology and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
This section covers regional segmentation which accentuates on current and future demand for peptide synthesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the peptide synthesis market include Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo Fisher, Creative Diagnostics, Polypeptide Group, Syngene, PuroSynth, Lonza, MP Biomedicals and Novo Nordisk A/S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.